Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit - PubMed (original) (raw)
. 1993 Dec 16;366(6456):707-10.
doi: 10.1038/366707a0.
Affiliations
- PMID: 8259216
- DOI: 10.1038/366707a0
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Y Gu et al. Nature. 1993.
Abstract
The major events of the cell division cycle are triggered by periodic changes in the activity of cyclin-dependent protein kinases (CDKs). In mammals, the members of the CDK family include CDK2 and CDC2, which are thought to be involved in the control of DNA replication and mitosis, respectively. The protein kinase activity of these enzymes is controlled by a complex array of mechanisms. Activation of the CDK catalytic subunit requires association with a positive regulatory subunit (cyclin) and phosphorylation (at Thr 160 in CDK2). This activated complex can be inhibited by additional phosphorylation at Thr 14 and Tyr 15. Here we report the identification of a new mechanism for the regulation of CDK2 activity. We find that CDK2/cyclin complexes in mouse fibroblasts associate tightly with a 20K protein (CAP20). Complexes containing CAP20 were isolated from cell lysates and found to have negligible kinase activity, indicating that CAP20 association in vivo may inhibit CDK2 activity. We purified CAP20 from 3T3 cells and found that low concentrations of the protein completely inhibit the kinase activity of CDK2 in vitro. Thus CAP20 represents a new negative regulatory subunit that inhibits the activity of CDK2/cyclin complexes in mammalian cells.
Comment in
- Cell cycle. Dams and sluices.
Nasmyth K, Hunt T. Nasmyth K, et al. Nature. 1993 Dec 16;366(6456):634-5. doi: 10.1038/366634a0. Nature. 1993. PMID: 8259207 No abstract available.
Similar articles
- Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G, Hunter T, Ruoslahti E. Orend G, et al. Oncogene. 1998 May;16(20):2575-83. doi: 10.1038/sj.onc.1201791. Oncogene. 1998. PMID: 9632134 - p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A. Fotedar R, et al. Oncogene. 1996 May 16;12(10):2155-64. Oncogene. 1996. PMID: 8668341 - PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
Kashiwagi M, Ohba M, Watanabe H, Ishino K, Kasahara K, Sanai Y, Taya Y, Kuroki T. Kashiwagi M, et al. Oncogene. 2000 Dec 14;19(54):6334-41. doi: 10.1038/sj.onc.1204028. Oncogene. 2000. PMID: 11175348 - [The characterization of human cdc2 kinase and CDK2].
Yasuda H, Kamijo M, Ohba Y. Yasuda H, et al. Yakugaku Zasshi. 1993 Dec;113(12):829-46. doi: 10.1248/yakushi1947.113.12_829. Yakugaku Zasshi. 1993. PMID: 8301538 Review. Japanese. - Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.
Johnson LN, De Moliner E, Brown NR, Song H, Barford D, Endicott JA, Noble ME. Johnson LN, et al. Pharmacol Ther. 2002 Feb-Mar;93(2-3):113-24. doi: 10.1016/s0163-7258(02)00181-x. Pharmacol Ther. 2002. PMID: 12191604 Review.
Cited by
- Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.
Takashima Y, Hayashi S, Fukuda K, Maeda T, Tsubosaka M, Kamenaga T, Kikuchi K, Fujita M, Kuroda Y, Hashimoto S, Nakano N, Matsumoto T, Kuroda R. Takashima Y, et al. Sci Rep. 2021 Jun 15;11(1):12516. doi: 10.1038/s41598-021-92055-9. Sci Rep. 2021. PMID: 34131243 Free PMC article. - Mammalian mitochondrial translation infidelity leads to oxidative stress-induced cell cycle arrest and cardiomyopathy.
Zheng WQ, Zhang JH, Li ZH, Liu X, Zhang Y, Huang S, Li J, Zhou B, Eriani G, Wang ED, Zhou XL. Zheng WQ, et al. Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2309714120. doi: 10.1073/pnas.2309714120. Epub 2023 Sep 5. Proc Natl Acad Sci U S A. 2023. PMID: 37669377 Free PMC article. - Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.
Aktas H, Cai H, Cooper GM. Aktas H, et al. Mol Cell Biol. 1997 Jul;17(7):3850-7. doi: 10.1128/MCB.17.7.3850. Mol Cell Biol. 1997. PMID: 9199319 Free PMC article. - Activity and nature of p21(WAF1) complexes during the cell cycle.
Cai K, Dynlacht BD. Cai K, et al. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12254-9. doi: 10.1073/pnas.95.21.12254. Proc Natl Acad Sci U S A. 1998. PMID: 9770473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous